Codexis
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Codexis and other ETFs, options, and stocks.About CDXS
Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments.
CDXS Key Statistics
Stock Snapshot
Codexis(CDXS) stock is priced at $1.70, giving the company a market capitalization of 152.55M. It carries a P/E multiple of -2.06.
On 2025-11-08, Codexis(CDXS) stock moved within a range of $1.59 to $1.88. With shares now at $1.70, the stock is trading +6.9% above its intraday low and -9.6% below the session's peak.
Trading activity shows a volume of 4.98M, compared to an average daily volume of 1.21M.
Over the past 52 weeks, Codexis(CDXS) stock has traded between a high of $6.08 and a low of $1.59.
Over the past 52 weeks, Codexis(CDXS) stock has traded between a high of $6.08 and a low of $1.59.
CDXS News
Earnings Call Insights Codexis signals transformation to full-service manufacturing innovator with ECO Synthesis platform and expects 2025 revenue at or above t...
Codexis ( (CDXS) ) has released its Q3 earnings. Here is a breakdown of the information Codexis presented to its investors. Meet Your ETF AI Analyst Discover...
Analyst Brendan Smith from TD Cowen maintained a Hold rating on Codexis and decreased the price target to $2.00 from $3.00. Meet Your ETF AI Analyst Discover ho...
Analyst ratings
71%
of 7 ratingsMore CDXS News
Reports Q3 revenue $8.6M, consensus $18.52M. “We’ve had a very exciting and important few months that have set us up very well for the changes we are announcing...
Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions AI Analyst can help you make smarter investment...